Revenue Recognition (Tables)

6 Months Ended

Jun. 30, 2022

Revenue Recognition

Schedule of disaggregation of revenues by payer types

	Three months ended				Six months ended
	June 30,				June 30,
	2022		2021		2022		2021
(in thousands)
Insurance carriers	$	167,822	$	118,396	$	332,564	$	218,795
Laboratory and other partners		22,142		15,599		42,879		60,134
Patients		8,236		8,031		16,890		15,413
Total revenues	$	198,200	$	142,026	$	392,333	$	294,342

Schedule of total revenue by geographic area

	Three months ended				Six months ended
	June 30,				June 30,
	2022		2021		2022		2021
(in thousands)
United States	$	191,886	$	134,814	$	379,103	$	279,771
Americas, excluding U.S.		530		992		1,271		1,805
Europe, Middle East, India, Africa		3,736		4,265		7,427		8,724
Asia Pacific and Other		2,048		1,955		4,532		4,042
Total revenues	$	198,200	$	142,026	$	392,333	$	294,342

Schedule of beginning and ending balances of accounts receivable and deferred revenues

	Balance at		Balance at
	June 30,		December 31,
(in thousands)	2022		2021
Assets:
Accounts receivable	$	208,312	$	122,074
Liabilities:
Deferred revenue, current portion	$	16,009	$	7,404
Deferred revenue, long-term portion		20,721		21,318
Total deferred revenues	$	36,730	$	28,722

Schedule of changes in the balance of deferred revenues

	June 30,			June 30,
	2022			2021
(in thousands)
Beginning balance	$	28,722	$	72,930
Increase in deferred revenues		14,974		3,474
Refunds of revenues previously deferred		—		(10,000)
Revenue recognized during the period that was included in deferred revenues at the beginning of the period		(5,757)		(30,839)
Revenue recognized from performance obligations satisfied within the same period		(1,209)		(1,356)
Ending balance	$	36,730	$	34,209